Exa-cel
VX21-CTX001-171
Phase 3 mab terminated
Quick answer
Exa-cel for Sickle Cell Disease is a Phase 3 program (mab) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Sickle Cell Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated